Healthcare Consulting Services Driving Growth Across Industry

A healthcare consulting and technology firm partners with organizations across pharmaceuticals, biotech, health plans, providers and medical technology to drive growth and improve outcomes. With over 40 years of experience, the firm combines strategy, AI, data and digital solutions to solve complex industry challenges, from drug development to patient care. For more info: https://www.zs.com/industry-insights/healthcare

Digital Strategy Advisory Services for Enterprise Transformation

Looking for digital strategy advisory that closes the gap between business vision and technology execution? This capability connects strategy to delivery, modernizes core technology and guides smart investments in data, digital and AI. It unifies data ecosystems, builds scalable, cloud-ready platforms and designs secure, responsible systems that drive lasting impact. For more info: https://www.zs.com/capabilitie....s/data-digital-techn

Healthcare Payer Consulting Solutions for Health Plans

Health plans today face rising costs, regulatory shifts and higher member expectations, requiring agile, sustainable operating models. Specialized healthcare payer consulting supports plans across AI adoption, digital innovation, quality improvement and member experience redesign, connecting clinical, financial and operational priorities. For more info: https://www.zs.com/industry-insights/health-plans

The Impact of Generative AI and Content Automation for Pharma

Generative AI is transforming pharmaceutical content by improving personalization, efficiency, and scalability. Content automation for pharma can help streamline content creation, tagging, approval, and deployment while supporting compliant processes. Combining AI with human expertise enables more relevant content, faster workflows, and stronger engagement across digital channels. For more info: https://www.zs.com/insights/ge....nerative-ai-pharma-c

Competitive Intelligence in Pharma: Strategy for Market Wins

Specialty pharma markets—oncology, immunology, rare disease—are more crowded than ever, making differentiation difficult. Success still comes from three drivers: predictive analytics to spot underserved patients early, structured competitor simulations to anticipate rival moves before they happen, and a deliberately designed customer experience that HCPs remember. For more info: https://www.zs.com/insights/sp....ecialty-markets-comp